Ed Price, was interviewed for Drug Development & Delivery magazine released on April. Discover more about the Contract Development and Manufacturing Organization (CDMO) sector…
Read moreMiddlesbrough & Billingham manufacturing sites joined the Seqens group in late 2017. The sites are celebrating their 150th year anniversary in the UK.
Read moreFrom 30th of April to 2nd of May at Chicago, meet our team in booth 217 Use our promo code INVITE19SEQENS for a…
Read moreEd Price, was interviewed for Drug Development & Delivery magazine released on April. Discover more about the Contract Development and Manufacturing Organization (CDMO) sector…
Read moreInterview of Karine SALIM, Global Category Manager, on pharmaceutical applications of polymers at Seqens. Seqens expertise in polymer development To date,…
Read moreMay 1st 2019, Seqens Cosmetics will launch ACT4S*.com blockchain technology. *Active Cosmetic Trust for Seqens. The first platform offering traceability of…
Read moreGlycuron™ 2.78, a high molecular weight polysaccharide rich in uronic acid produced by biotechnology Glycuron™ 2.78 is produced by Alteromonas sp strain.
Read moreSeqens Cosmetics, functional care (formerly Chemoxy), launches ChemoxyCare® 6, 1,2-Hexanediol with best in class quality profile.
Read moreDiscover Seqens Advanced Specialties and our activity thanks to the interview of Francis Belanger, Global Electronic Market Manager.
Read moreSEQENS CDMO and SEQENS EDS attended DCAT WEEK The fruitfulness of all engagements, be it meeting with customers/partners in the suites, attending the…
Read more